An innovative cold tail-flick test: The cold ethanol tail-flick test

J. J. Wang, S. T. Ho, O. Y.P. Hu, K. M. Chu

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

An innovative antinociceptive test, the cold ethanol tail-flick test (CET), was developed for evaluating the actions of opioid analgesics. To select an optimal operation temperature range for the CET, temperatures from -5°C to -30°C were screened. After screening, temperatures ranging between -20°C and -30°C were both strong and effective enough to act as a noxious cold stimulus. In the following study, -20°C was selected as the cold stimulus for the CET. The sensitivity and specificity of this test were challenged by opioid analgesics: an agonist (morphine) and two agonist- antagonists (buprenorphine and nalbuphine), two tranquilizers (droperidol and diazepam), and four nonopioid analgesics (acetaminophen, aspirin, indomethacin,and ketoprofen). The sensitivity of the CET was also compared with the assays using heat (radiant heat and hot water). The AD50 values determined by the CET for morphine, buprenorphine, and nalbuphine were 0.16 mg/kg, 0.22 μg/kg, and 0.19 mg/kg, respectively. Naloxone, an opioid antagonist, blocked the antinociceptive effects of these opioids which were determined by the CET. Furthermore, the tranquilizers and nonopioid analgesics did not show any activity in the CET. Our results show that not only can the CET assess the antinociceptive activity of both opioid agonist and mixed agonist-antagonist, it also possess the characteristics of sensitivity, specificity, simplicity, and reproducibility.

Original languageEnglish
Pages (from-to)102-107
Number of pages6
JournalAnesthesia and Analgesia
Volume80
Issue number1
DOIs
Publication statusPublished - Jan 4 1995
Externally publishedYes

Fingerprint

Ethanol
Opioid Analgesics
Nalbuphine
Non-Narcotic Analgesics
Buprenorphine
Morphine
Hot Temperature
Droperidol
Ketoprofen
Sensitivity and Specificity
Temperature
Narcotic Antagonists
Acetaminophen
Diazepam
Naloxone
Indomethacin
Aspirin
Water

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

An innovative cold tail-flick test : The cold ethanol tail-flick test. / Wang, J. J.; Ho, S. T.; Hu, O. Y.P.; Chu, K. M.

In: Anesthesia and Analgesia, Vol. 80, No. 1, 04.01.1995, p. 102-107.

Research output: Contribution to journalArticle

Wang, J. J. ; Ho, S. T. ; Hu, O. Y.P. ; Chu, K. M. / An innovative cold tail-flick test : The cold ethanol tail-flick test. In: Anesthesia and Analgesia. 1995 ; Vol. 80, No. 1. pp. 102-107.
@article{05851ff8c64245b28ed43d389ade8aa2,
title = "An innovative cold tail-flick test: The cold ethanol tail-flick test",
abstract = "An innovative antinociceptive test, the cold ethanol tail-flick test (CET), was developed for evaluating the actions of opioid analgesics. To select an optimal operation temperature range for the CET, temperatures from -5°C to -30°C were screened. After screening, temperatures ranging between -20°C and -30°C were both strong and effective enough to act as a noxious cold stimulus. In the following study, -20°C was selected as the cold stimulus for the CET. The sensitivity and specificity of this test were challenged by opioid analgesics: an agonist (morphine) and two agonist- antagonists (buprenorphine and nalbuphine), two tranquilizers (droperidol and diazepam), and four nonopioid analgesics (acetaminophen, aspirin, indomethacin,and ketoprofen). The sensitivity of the CET was also compared with the assays using heat (radiant heat and hot water). The AD50 values determined by the CET for morphine, buprenorphine, and nalbuphine were 0.16 mg/kg, 0.22 μg/kg, and 0.19 mg/kg, respectively. Naloxone, an opioid antagonist, blocked the antinociceptive effects of these opioids which were determined by the CET. Furthermore, the tranquilizers and nonopioid analgesics did not show any activity in the CET. Our results show that not only can the CET assess the antinociceptive activity of both opioid agonist and mixed agonist-antagonist, it also possess the characteristics of sensitivity, specificity, simplicity, and reproducibility.",
author = "Wang, {J. J.} and Ho, {S. T.} and Hu, {O. Y.P.} and Chu, {K. M.}",
year = "1995",
month = "1",
day = "4",
doi = "10.1097/00000539-199501000-00018",
language = "English",
volume = "80",
pages = "102--107",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - An innovative cold tail-flick test

T2 - The cold ethanol tail-flick test

AU - Wang, J. J.

AU - Ho, S. T.

AU - Hu, O. Y.P.

AU - Chu, K. M.

PY - 1995/1/4

Y1 - 1995/1/4

N2 - An innovative antinociceptive test, the cold ethanol tail-flick test (CET), was developed for evaluating the actions of opioid analgesics. To select an optimal operation temperature range for the CET, temperatures from -5°C to -30°C were screened. After screening, temperatures ranging between -20°C and -30°C were both strong and effective enough to act as a noxious cold stimulus. In the following study, -20°C was selected as the cold stimulus for the CET. The sensitivity and specificity of this test were challenged by opioid analgesics: an agonist (morphine) and two agonist- antagonists (buprenorphine and nalbuphine), two tranquilizers (droperidol and diazepam), and four nonopioid analgesics (acetaminophen, aspirin, indomethacin,and ketoprofen). The sensitivity of the CET was also compared with the assays using heat (radiant heat and hot water). The AD50 values determined by the CET for morphine, buprenorphine, and nalbuphine were 0.16 mg/kg, 0.22 μg/kg, and 0.19 mg/kg, respectively. Naloxone, an opioid antagonist, blocked the antinociceptive effects of these opioids which were determined by the CET. Furthermore, the tranquilizers and nonopioid analgesics did not show any activity in the CET. Our results show that not only can the CET assess the antinociceptive activity of both opioid agonist and mixed agonist-antagonist, it also possess the characteristics of sensitivity, specificity, simplicity, and reproducibility.

AB - An innovative antinociceptive test, the cold ethanol tail-flick test (CET), was developed for evaluating the actions of opioid analgesics. To select an optimal operation temperature range for the CET, temperatures from -5°C to -30°C were screened. After screening, temperatures ranging between -20°C and -30°C were both strong and effective enough to act as a noxious cold stimulus. In the following study, -20°C was selected as the cold stimulus for the CET. The sensitivity and specificity of this test were challenged by opioid analgesics: an agonist (morphine) and two agonist- antagonists (buprenorphine and nalbuphine), two tranquilizers (droperidol and diazepam), and four nonopioid analgesics (acetaminophen, aspirin, indomethacin,and ketoprofen). The sensitivity of the CET was also compared with the assays using heat (radiant heat and hot water). The AD50 values determined by the CET for morphine, buprenorphine, and nalbuphine were 0.16 mg/kg, 0.22 μg/kg, and 0.19 mg/kg, respectively. Naloxone, an opioid antagonist, blocked the antinociceptive effects of these opioids which were determined by the CET. Furthermore, the tranquilizers and nonopioid analgesics did not show any activity in the CET. Our results show that not only can the CET assess the antinociceptive activity of both opioid agonist and mixed agonist-antagonist, it also possess the characteristics of sensitivity, specificity, simplicity, and reproducibility.

UR - http://www.scopus.com/inward/record.url?scp=0028796778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028796778&partnerID=8YFLogxK

U2 - 10.1097/00000539-199501000-00018

DO - 10.1097/00000539-199501000-00018

M3 - Article

C2 - 7802265

AN - SCOPUS:0028796778

VL - 80

SP - 102

EP - 107

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 1

ER -